Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telemonitoring and Treprostinil for Group 2 Pulmonary Hypertension
NCT04882774Phase 2Withdrawn
- Start
- Apr 2023
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in pulmonary hypertension (PH). Planned start Apr 2023; status: withdrawn.
02
Drugs
treprostinil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04882774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882774.